Findings

What do systematic reviews say?

2 questions · 2 findings · 2 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 1 · 50%Moderate 1 · 50%High 0 · 0%

Withdrawals due to adverse events · patients with induction of remission in ulcerative colitis

Type I Interferons may leads to higher withdrawals due to adverse events compared with placebo (low certainty).

1 finding from 1 review

Type I interferons for induction of remission in ulcerative colitis 2015 · Cochrane Headline outcomes only
RR 3.16 [1.06, 9.4]
4 studies · 394 participants
Low

Withdrawals due to adverse events · patients with relapsing‐remitting multiple sclerosis

Fingolimod 0.5 mg showed no clear difference in withdrawals due to adverse events compared with interferon beta‐1a (moderate certainty).

1 finding from 1 review

Fingolimod for relapsing‐remitting multiple sclerosis 2016 · Cochrane Headline outcomes only
RR 1.51 [0.81, 2.8]
1 study · 860 participants
Moderate